Vitamin D Status After Single Oral Dose of Cholecalciferol in Low Fat Meal Compared to High-fat Meal (VITDAB_08606)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the absorption of dietary supplement of vitamin D3 (cholecalciferol), through the variation of 25 (OH) D levels, as the fat content of the meal associated with the administration of the supplement.
| Condition | Intervention |
|---|---|
|
Deficiency, Vitamin D |
Dietary Supplement: colecalciferol |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Pharmacokinetics Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Vitamin D Status After Single Oral Dose of Cholecalciferol in Low Fat Meal Compared to High-fat Meal |
- Serum Level of Vitamin D3 [ Time Frame: 14 days ] [ Designated as safety issue: Yes ]
| Enrollment: | 30 |
| Study Start Date: | August 2009 |
| Study Completion Date: | October 2009 |
| Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Low fat meal |
Dietary Supplement: colecalciferol
50.000UI single oral dose
|
| Experimental: Hight fat meal |
Dietary Supplement: colecalciferol
50.000UI single oral dose
|
Detailed Description:
Clinical randomized controlled double-blind study with healthy subjects to investigate the effect of low and high fat of meal on absorption of vitamin D supplement. Participants were randomly in two groups according to sex and BMI.
In the same date, each group of participants received a meal and dietary supplement of vitamin D3 (cholecalciferol) after the first blood sample and a urine sample. Others samples were collected in the seventh and fourteenth day after intake the supplement.
Eligibility| Ages Eligible for Study: | 20 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Residents of the hospital clinics of Porto Alegre
Exclusion Criteria:
- Don't drink milk
- Obesity
- Malnutrition
- Liver disease
- Kidney disease or diabetes
- Use of dietary supplements containing calcium and vitamin D
- Medications
- Anticonvulsants
- Barbiturates, or steroids.
- Having performed a journey the last four months to locations near the Earth's equatorial plane, due to sun exposure that may have occurred during this period, or vacations planned during the study period.
Contacts and Locations| Brazil | |
| Hospital de Clínicas de Porto Alegre | |
| Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 | |
| Principal Investigator: | Fabiana Viegas Raimundo, graduation | Federal University of Rio Grande do Sul |
| Study Director: | Tania Weber Furlanetto, PhD | Federal University of Rio Grande do Sul |
| Principal Investigator: | Gustavo Faulhaber, Master | Federal University of Rio Grande do Sul |
| Principal Investigator: | Rosana Scalco, Master | Hospital de Clínicas de Porto Alegre |
| Principal Investigator: | Leonardo Marques, Graduation | Hospital de Clínicas de Porto Alegre |
| Principal Investigator: | Paula Menegatti, Graduation | Hospital de Clínicas de Porto Alegre |
More Information
No publications provided
| Responsible Party: | Fabiana Viegas Raimundo, Universidade Federal do Rio Grande do Sul |
| ClinicalTrials.gov Identifier: | NCT00968734 History of Changes |
| Other Study ID Numbers: | FIPE, CAPES, GPPG_080606 |
| Study First Received: | August 28, 2009 |
| Last Updated: | March 4, 2010 |
| Health Authority: | Brazil: Ethics Committee |
Keywords provided by Federal University of Rio Grande do Sul:
|
Vitamin D colecalciferol absorption by Vitamin D |
Additional relevant MeSH terms:
|
Vitamin D Deficiency Avitaminosis Deficiency Diseases Malnutrition Nutrition Disorders Cholecalciferol Vitamin D |
Ergocalciferols Vitamins Micronutrients Growth Substances Physiological Effects of Drugs Pharmacologic Actions Bone Density Conservation Agents |
ClinicalTrials.gov processed this record on May 19, 2013